Polar Capital to launch biotechnology fund - FT Adviser

23-09-2013 FT AdviserComments (0)

Biotechnology

Polar Capital to launch biotechnology fund
FT Adviser
Biotechnology has been the best-performing investment sector in recent years and the £229.3m Axa Framlington Biotech fund is the best-performing fund in the IMA universe in the past three years. Polar Capital hired a former manager of the Axa fund ...

Read more on FT Adviser

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top